Ascendis ready for new hires after FDA approval
![Photo: Kevin Grønnemann/MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11298514.ece/ALTERNATES/schema-16_9/ascendis.jpg)
Ascendis Pharma is chomping at the bit after securing a long-awaited approval for Transcon hGH, which will be marketed as Skytrofa. The company has already prepared launch plans to be initiated immediately.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA approves Ascendis' weekly growth hormone
For subscribers
Ascendis aiming to become market leader
For subscribers